Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
AstraZeneca
Daiichi Sankyo
McKinsey
UBS
Johnson and Johnson
Federal Trade Commission
Express Scripts

Generated: April 24, 2018

DrugPatentWatch Database Preview

LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

When do Levaquin In Dextrose 5% In Plastic Container patents expire, and what generic alternatives are available?

Levaquin In Dextrose 5% In Plastic Container is a drug marketed by Janssen Pharms and is included in one NDA.

The generic ingredient in LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER is levofloxacin. There are thirty drug master file entries for this compound. Fifty-nine suppliers are listed for this compound. Additional details are available on the levofloxacin profile page.
Summary for LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Drug patent expirations by year for LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Medical Subject Heading (MeSH) Categories for LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Synonyms for LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER
(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyridol[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate
(-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7Hpyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate
(-)-Ofloxacin
(-)-Ofloxacin; (-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazin-yl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
()-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1;()-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1
(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.0^{5,13}]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.0;{5,13}]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
(3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
(3s)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7h-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
(3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
(R)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(R)-isomer
(S)-(-)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid
(S)-(-)-Ofloxacin
(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(S)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]-benzoxazine-6-carboxylic acid
(S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
(S)-Ofloxacin
100986-85-4
7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 2,3-dihydro-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (S)-
7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 2,3-dihydro-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, hemihydrate, (S)-
7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (3S)-
986L854
AB00171657_14
AB00171657_15
AB00171657-12
AB00171657-13
AB0072147
AB1009501
AC-7593
AC1L3YF8
Aeroquin
AJ-23383
AK163316
AKOS008901361
AKOS015895104
Ambap100986-85-4
AN-8873
API0007780
BDBM50366826
BG0235
BIL1009
BRD-K09471561-001-06-7
BSPBio_002689
C07660
C18H20FN3O4
C18H20FN3O4.H2O
CCG-39093
CCRIS 4073
CCRIS 4074
CHEBI:63598
CPD000466387
Cravit
Cravit (TN)
Cravit IV
Cravit Ophthalmic
CS-2218
D02RSN
D08120
DB01137
DE-108
DR 3354
DR-3355
DR-3355: L-isomer of ofloxacin
DR3355
DRG-0129
DTXSID0041060
EBD8264
Elequine
EX-A1488
Floxacin
Floxel
fluoro-methyl-(4-methylpiperazin-1-yl)-oxo-[?]carboxylic acid
FT-0627808
GSDSWSVVBLHKDQ-JTQLQIEISA-N
HE289197
HMS1922J07
HMS2051G04
HMS2090O10
HMS2093E18
HMS2232G06
HR 355
HR-355
HSDB 8028
HY-B0330
Iquix
Iquix (TN)
KBio2_002199
KBio2_004767
KBio2_007335
KBio3_001909
KBioGR_001605
KBioSS_002199
L-Ofloxacin
L0193
Leroxacin
Lesacin
Levaquin
Levaquin (TN)
Levo Floxacin
Levofiexacin
LEVOFLOXACIN
Levofloxacin (INN)
Levofloxacin (Levaquin)
Levofloxacin [USAN:INN:JAN]
Levofloxacin Anhydrous
Levofloxacin hydrate
Levofloxacin solution, 1.0 mg/mL in acetonitrile, certified reference material
Levofloxacin tablet, suspension or intravenous
Levofloxacin, >=98.0% (HPLC)
Levofloxacin, analytical reference material
Levofloxacin, Antibiotic for Culture Media Use Only
Levofloxacine
Levofloxacine [INN-French]
Levofloxacino
Levofloxacino [INN-Spanish]
Levofloxacinum
Levofloxacinum [INN-Latin]
Levokacin
Levox
Levoxacin
LFX
Loxof
LS-133260
LS-171761
LVFX; RWJ 25213; L-Ofloxacin; Ophthalmic; (-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazin-yl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
LVX
MCULE-2011834955
MLS000759524
MLS001165709
MLS001423977
MMV687798
MolPort-002-885-835
Mosardal
MP 376
MP-376
NC00094
NCGC00178529-01
NCGC00178529-03
Nofaxin
NSC-758709
NSC758709
Ofloxacin S-(-)-form
Oftaquix
Oftaquix (TN)
Pharmakon1600-01504260
Q-201295
Quixin
Quixin (TN)
R-Ofloxacin
Reskuin
RIX4E89Y14
RWJ 25213-097
RWJ-25213
S-(-)-Ofloxacin
s1940
SAM001246758
SBI-0206768.P001
SCHEMBL15397
SMR000466387
SPBio_001891
Spectrum_001719
SPECTRUM1504260
Spectrum2_001676
Spectrum3_000995
Spectrum4_001123
Spectrum5_001438
SR-05000001999
SR-05000001999-1
ST24047487
Tavanic
Tavanic (TN)
Unibiotic
UNII-A4P49JAZ9H component GSDSWSVVBLHKDQ-JTQLQIEISA-N
UNII-RIX4E89Y14
Venaxan
Volequin
Z1766089137
ZINC538273
ZX-AFC000651

US Patents and Regulatory Information for LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharms LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER levofloxacin INJECTABLE;INJECTION 020635-002 Dec 20, 1996 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Janssen Pharms LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER levofloxacin INJECTABLE;INJECTION 020635-003 Dec 20, 1996 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Janssen Pharms LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER levofloxacin INJECTABLE;INJECTION 020635-005 Dec 20, 1996 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER levofloxacin INJECTABLE;INJECTION 020635-003 Dec 20, 1996 ➤ Sign Up ➤ Sign Up
Janssen Pharms LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER levofloxacin INJECTABLE;INJECTION 020635-003 Dec 20, 1996 ➤ Sign Up ➤ Sign Up
Janssen Pharms LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER levofloxacin INJECTABLE;INJECTION 020635-002 Dec 20, 1996 ➤ Sign Up ➤ Sign Up
Janssen Pharms LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER levofloxacin INJECTABLE;INJECTION 020635-005 Dec 20, 1996 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Teva
Healthtrust
Farmers Insurance
McKinsey
Fish and Richardson
Johnson and Johnson
Merck
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.